Altria Group has an outstanding long-term track record of creating value for shareholders.

From 2013 to 20181 we produced adjusted diluted earnings per share growth at a compounded annual rate of approximately 10.9 percent2 and we’ve consistently grown our dividend. Over this period, we’ve produced total shareholder returns of 59.2 percent, which exceed both the S&P 500 and S&P Food, Beverage and Tobacco Index.

Recognition

Altria ranked third on the 2016 Barron's 500 list.

Altria ranked 91st on Barron's 2015 World's Most Respected Companies list, as determined by institutional investors.

Strategies for Long-Term Growth

Altria is focused on the following strategies to create substantial value for its shareholders:

dollar sign

Maximize income from our
core tobacco businesses

bar chart showing positive growth

Grow income over time with
non-combustible tobacco products

hands surrounding dollar signs

Manage our diverse income
streams and strong balance sheet
to deliver consistent financial
performance over the long term


Altria's Enhanced Business Platform

Complementary
Assets


Marlboro snippet

 

Marlboro
Leading cigarette brand

Black & Mild snippet

 

Black & Mild
Leading tipped cigar brand

Parliament and Nat Sherman stacked snippet

 

Cigarette Portfolio
Highly profitable niche brands

Combustible
Tobacco Portfolio


Copenhagen snippet

 

Copenhagen

Leading MST brand

IQOS snippet

 

IQOS
Global heat-not-burn leader
(U.S. License)

JUUL snippet

 

JUUL
Leading e-vapor brand
(strategic investment)

on! snippet

 

on!
Oral nicotine pouches
(strategic investment)

Non-Combustible Tobacco
Brands & Investments


Ste. Michele logo

Top 10 domestic wine producer

AB InBev logo

~10% investment global beer industry leader

CRONOS logo

Emerging global cannabinoid company
(strategic investment)


Our 2008 Financial Performance3

Net Revenues ($ in millions)

$25,744

2016

$25,576

2017

$25,364

2018

Annualized Dividends per Share

$2.44

August 2016

$2.64

August 2017

$3.20

August 2018


Other 2018 Direct Economic Value4

$70.5M

in cash contributions to communities

$290M

in charges
for FDA user fees

$5,737M

million in excise taxes on products sold

$5,415M

in dividends paid on common stock

$618M

paid against pension and post-retirement benefits

$4,199M

in charges to state settlement agreements


1December 31, 2013 - December 31, 2018
2Click here for reconciliations of non-GAAP financial measures.
3Altria 2018 Full-Year Earnings Results
4Altria Group, Inc. 2018 Annual Report
*Conversion of Altria’s 35% economic interest to a 35% economic and voting interest remains subject to regulatory review.